Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium valproate-loaded nanospanlastics in patchy alopecia areata
NCT05017454Phase 1Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- May 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of valproic acid in alopecia areata, sponsored by Kasr Al Ainy Hospital. Primary endpoint: Treatment success at 6 months. Started May 2021; status: completed.
02
Drugs
valproic acid
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05017454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017454.